Galectin-3 and prohibitin 1 autoantibody positivity have previously been assessed in more clinically diverse cohorts of people with IgG4-RD who had multiorgan manifestations. The gene discussed is PHB1; the disease is immunoglobulin G4-related sclerosing disease.